Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The infectious disease work will likely be led by a vaccine veteran: Peter Marks, who assumed the role of Lillys senior vice president for molecule discovery and the head of infectious diseases a few months after stepping down as director of FDAs Center for Biologics Evaluation and Research in March 2025
Retatrutide directly boosts metabolic rate through glucagon receptor activation
This matters commercially because the same biological pathway can support multiple high-burden conditions that are often present in the same patient population
Health care insurance coverage for GLP-1 drugs is spotty, and many large health plans have declined to include them in their formularies
![Structure of [ 3 H]liraglutide (top) and the GLP-1 receptor agonists](https://www.researchgate.net/profile/Inga-Bjornsdottir-2/publication/45650716/figure/fig2/AS:667822585806848@1536232720030/Structure-of-3-Hliraglutide-top-and-the-GLP-1-receptor-agonists-liraglutide-and.png)
